Truxima

Say hello to Roche's worst-case scenario: Teva's Rituxan biosim set to launch in U.S.
Fierce Pharma
Thu, 11/7/19 - 11:05 am
Roche
Teva Pharmaceutical
Celltrion
Rituxan
biosimilars
MabThera
Truxima
FDA approves first biosimilar for NHL
BioCentury
Thu, 11/29/18 - 12:00 am
Celltrion
Teva Pharmaceutical
non-Hodgkin's lymphoma
Truxima
biosimilars
rituximab